Dermatomyositis-like features occurring after allogeneic BMT were thought to be a rare presentation of chronic GVHD (cGVHD). [1] [2] [3] [4] Herein, we report a male patient who developed dermatomyositis 14 years after allogeneic BMT. This 24-year-old man was admitted to our hospital with myalgia and muscle weakness in his upper and lower extremities. Examination of his medical history revealed that he had received an allogeneic BMT from an HLAmatched unrelated female donor as a rescue for relapsed ALL at the age of 10 years. The transplant was performed with a conditioning regimen of BU, CY and etoposide with a GVHD prophylaxis of CsA and short-term MTX. A complete engraftment was obtained on day 16. Genotyping using XY-FISH analysis of a BM sample taken at day 26 revealed that 98.8% of whole nucleated cells were of donor origin, suggesting that complete chimera was achieved. The post-transplant course was smooth and uneventful with grade 1 acute GVHD of the skin. Since day 368, he has been free from immunosuppressants for over a decade.
On admission, he complained of proximal muscle weakness at all his extremities, with a grade 3/5 on Medical Research council scale. Otherwise, there were no abnormal neurological findings. His skin was dry and thickened over the entire body, with scattered itchy/scaly papules suggesting the presence of cGVHD. Skin biopsy confirmed fibrosing dermatitis and hypertrophic sclerosis. In addition, a heliotrope rash of the face and Gottron's papules on the extensor surfaces were noted, indicating that he may have dermatomyositis rather than cGVHD. Laboratory examinations showed elevated values of creatine phosphokinase (1842 IU/L; reference values 36-177 IU/L), aspartate aminotransferase (108 IU/L; reference values 12-35 IU/L) and lactate dehydrogenase (697 IU/L; reference values 114-243 IU/L). The anti-nuclear Ab was positive at 1:640, but anti Jo-1 Ab was negative. A T2-weighed magnetic resonance imaging scan showed high signals in the deltoid and trapezius muscles. An electromyogram of the right deltoid showed fibrillations, and short-duration low-amplitude motor-unit potentials, consistent with a myopathic process. Muscle biopsy of the left deltoid demonstrated that muscle fiber was remarkably atrophic in the perifascicular areas. A substantial number of inflammatory mononuclear cells were noted in the endomysium, perimysium and perivascular regions. These infiltrating cells were predominantly CD4 þ (Figures 1a-c) . At this time, re-analysis of XY-FISH of whole nucleated cells in peripheral blood revealed that XY-positive cells increased up to 87%, indicating that he was in a mixed chimeric status. Therefore, to determine the origin of infiltrating CD4 þ cells, genotyping with XY-FISH analysis was carried out using a paraffin-embedded muscle specimen. It was revealed that infiltrating cells in the muscle clearly had a Y-positive phenotype (Figure 1d ). On the basis of these findings, he was diagnosed with autoimmune dermatomyositis and not cGVHD, and treated with 60 mg/day oral prednisolone. His muscle weakness improved dramatically in a few days, and his creatine phosphokinase level decreased to 281 IU/L in 2 weeks. The prednisolone was gradually tapered to 20 mg/day over the following 4 months. At 6 months after admission, he had no recurrence of any muscle weakness or myalgia, and his skin eruption had improved. Although dermatomyositis is often associated with malignancy, there was no symptom or laboratory abnormal finding related to the presence of malignant disease including recurrence of ALL at the time of diagnosis. Furthermore, BM examination also confirmed no recurrence of ALL 18 months after the diagnosis of dermatomyositis.
Both polymyositis and dermatomyositis can occur after BMT. 5 Dermatomyositis shows skin manifestations including a heliotrope rash and Gottron's papules. 6, 7 However, cGVHD-related muscle complications of fascilitis/myositis are very rare. We found only six cases of BMT-related dermatomyositis in the literature, [1] [2] [3] [4] which developed at 4-52 months after transplantation. Of a total of seven cases including ours, patients were aged 24-51 years, four were female, and five were diagnosed histopathologically. However, only ours was characterized for the immunophenotypes and genotyping of infiltrating mononuclear cells, which showed predominantly recipient-type CD4 þ T-cell infiltration, compatible with the findings of dermatomyositis. 6, 7 However, in cGVHD-related diseases, interactions between donor CD8 þ cells and host cells must take place, which lead to the inflammatory disease.
Clinical features of dermatomyositis/juvenile dermatomyositis can sometimes resemble those of cGVHD. 8 Maternal microchimerism may have a role in the immunopathogenesis of juvenile dermatomyositis, where chimeric cells include high frequencies of IFN-a-secreting T cells in response to host cells. [6] [7] [8] However, it is undetermined whether the chimeric CD4 þ T cell itself attacks host cells in targeted organs in (juvenile) dermatomyositis patients. 
